Linked Life Data

8256454

Source:http://linkedlifedata.com/resource/pubmed/id/8256454

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14-15
pubmed:dateCreated
1994-1-11
pubmed:abstractText
The present chapter deals with postmenopausal osteoporosis. This is an important disease because it affects millions of people throughout the world. The most serious of the osteoporotic fractures, the hip fractures, needs hospitalization, causes a high degree of mortality, and results often in dependent people. Osteoporosis is thus a significant socioeconomic burden. At the menopause bone turnover increases and bone loss accelerates. Postmenopausal bone loss and osteoporosis may be prevented by oestrogen replacement therapy, but convincing therapy for established osteoporosis does not yet exist. Anabolic steroid therapy can, however, increase the bone mineral content a few percentages a year in postmenopausal osteoporotic women.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0043-5341
pubmed:author
pubmed:issnType
Print
pubmed:volume
143
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
389-91
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Epidemiology, biochemistry and some results with treatment of postmenopausal osteoporosis.
pubmed:affiliation
Center for Clinical and Basic Research, Ballerup, Denmark.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial